Abstract
In general, the term matrix device implies a drug delivery system in which the drug is dispersed, either molecularly or as solid drug particles, within a polymer network. Within this context at least four different types of devices can be envisioned. These include: i) dissolved matrix devices wherein the drug is dissolved within a crosslinked polymer at or below the saturation solubility of drug in the polymer; ii) dispersed matrix devices in which drug is dispersed as discrete solid particles within a polymer such that the concentration of the drug far exceeds its saturation solubility in the polymer; iii) porous matrix devices which are analogous to dispersed devices except that the initial drug load is sufficient to produce contiguous channels throughout the polymer network; and iv) surface treated devices which have a core which is analogous to types i)–iii) and a surface layer which is of much lower permeability to the drug than is the core.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Henry Malinowski, “Regulatory review of oral-controlled drug administration: Biopharmaceutics and medical requirements”, in: “Oral Controlled Drug Administration”, Y.W. Chien, ed., in press
T. Higuchi, J. Pharm. Sci., 50: 874 (1961).
T.J. Roseman, W.I. Higuchi, J. Pharm. Sci., 59: 353 (1970).
S.Z. Song, J.R. Cardinal, K. Sharma, J. Pharm. Sci., submitted.
J.C. Fu, C. Hagemeir, D.L. Moyer, E.W. Ny, J. Biomed. Mat. Res., 10: 743 (1976).
D.R. Paul, S.K. McSpadden, J. Membr. Sci., 1: 33 (1976).
R.W. Baker, H.K. Lonsdale, “Controlled release: Mechanism and rates”, in: “Advances in Experimental Biology and Medicine” Vol. 47, A.C. Tanquary, R.E. Lacey, eds., Plenum Press, New York (1974).
S.Z. Song, J.R. Cardinal, S.H. Kim, S.W. Kim, J. Pharm. Sci., 70: 216 (1981).
S.K. Chandrasekaran, R. Hillman, J. Pharm. Sci., 69: 1311 (1980).
R. Gurny, E. Doel Ker, N.A. Peppas, Biomaterials, 3: 27 (1982)
S.K. Chandrasekaran, D.R. Paul, J. Pharm. Sci., 71: 1399 (1982).
F. Theeuwes, U.S. Patent #4, 217, 898 (1980).
R.A. Lipper, W.I. Higuchi, J. Pharm. Sci., 66: 163 (1977).
D.S.T. Hsieh, W.D. Rhine, R. Langer, J. Pharm. Sci., 72: 17 (1983).
F. Theeuwes, U.S. Patent #4,217,898 (1980).
E.S. Lee, S.W. Kim, S.H. Kim, J.R. Cardinal, H. Jacobs, J. Membr. Sci., 7: 293 (1980).
K. Sharma, J.R. Cardinal, T.J. Roseman, J.J. Biermacker (Unpublished results).
T.J. Roseman, S.H. Yalkowski, “Importance of solute partitioning on the kinetics of drug release from matrix systems”, in: “Controlled Release Polymeric Formulations”, D.R. Paul, F.W. Harris, eds., American Chemical Society, Washington, D.C. (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag US
About this chapter
Cite this chapter
Cardinal, J.R. (1984). Drug Release from Matrix Devices. In: Anderson, J.M., Kim, S.W. (eds) Recent Advances in Drug Delivery Systems. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2745-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2745-5_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9700-0
Online ISBN: 978-1-4613-2745-5
eBook Packages: Springer Book Archive